tiprankstipranks
Advertisement
Advertisement
Court revives suit against Bristol Myers over delayed drug, Reuters reports
PremiumThe FlyCourt revives suit against Bristol Myers over delayed drug, Reuters reports
12d ago
Bristol Myers’ first CELMoD myeloma therapy granted accelerated FDA approval
Premium
The Fly
Bristol Myers’ first CELMoD myeloma therapy granted accelerated FDA approval
12d ago
Balanced Risk-Reward Keeps Bristol-Myers Squibb at Hold as Zenbexus CELMoD Opportunity Awaits Key 2026 Data
Premium
Ratings
Balanced Risk-Reward Keeps Bristol-Myers Squibb at Hold as Zenbexus CELMoD Opportunity Awaits Key 2026 Data
14d ago
Bristol Myers upgraded to Buy from Hold at Argus
PremiumThe FlyBristol Myers upgraded to Buy from Hold at Argus
23d ago
Bristol Myers, AstraZeneca not engaged in merger talks, Reuters reports
Premium
The Fly
Bristol Myers, AstraZeneca not engaged in merger talks, Reuters reports
23d ago
Schrodinger announces collaboration, software agreement with Bristol Myers
Premium
The Fly
Schrodinger announces collaboration, software agreement with Bristol Myers
23d ago
Video: Bristol Myers jumps, AstraZeneca sinks on report of tie-up talks
PremiumThe FlyVideo: Bristol Myers jumps, AstraZeneca sinks on report of tie-up talks
25d ago
Citi views report of AstraZeneca, Bristol Myers talks as surprising
Premium
The Fly
Citi views report of AstraZeneca, Bristol Myers talks as surprising
25d ago
Bristol Myers price target raised to $70 from $66 at Citi
Premium
The Fly
Bristol Myers price target raised to $70 from $66 at Citi
25d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100